Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

216.88 +4.30 (+2.02%)
Streaming Delayed Price Updated: 2:58 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 193,301
Open 214.63
Bid (Size) 216.88 (1)
Ask (Size) 216.96 (2)
Prev. Close 212.58
Today's Range 213.80 - 216.93
52wk Range 189.40 - 253.67
Shares Outstanding 146,234,244
Dividend Yield 0.72%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Incredible Growth Stocks to Buy Right Now
These mid-cap growth stocks could deliver market-beating returns in 2023 and beyond. 
Via The Motley Fool
$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga

Performance

YTD
+3.72%
+3.72%
1 Month
+2.53%
+2.53%
3 Month
+4.83%
+4.83%
6 Month
+0.83%
+0.83%
1 Year
-10.56%
-10.56%

More News

Read More
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
From ResMed Inc.
Via Globe NewsWire
ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
From ResMed Inc.
Via Globe NewsWire
ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
From ResMed Inc.
Via Globe NewsWire
$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Hopeful Golden Cross Forms On ResMed's Chart
Via Benzinga
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
From ResMed Inc.
Via Globe NewsWire
ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
From ResMed Inc.
Via Globe NewsWire
A Preview Of ResMed's Earnings
Via Benzinga
ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
From ResMed Inc.
Via Globe NewsWire
Where ResMed Stands With Analysts
Via Benzinga
Earnings Scheduled For January 26, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via Globe NewsWire
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
From ResMed Inc.
Via Globe NewsWire
Looking Into ResMed's Return On Capital Employed
Via Benzinga
Company Report Roundup: Tesla, Tractor Supply, American Express, and More
Via The Motley Fool
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
From ResMed Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
Via Benzinga
Earnings Scheduled For October 27, 2022
Via Benzinga
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
From ResMed Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Via Benzinga
Silk Road Medical Stock Scores Relative Strength Rating Upgrade
Via Investor's Business Daily
Hopeful Golden Cross Forms On ResMed's Chart
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.